Year All2026202520242023202220212020201920182017201620152014 Mar 06, 2024 Soleno Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full-Year 2023 Financial Results Feb 22, 2024 Soleno Therapeutics to Present at the TD Cowen 44th Annual Health Care Conference Feb 01, 2024 Soleno Therapeutics to Present at Upcoming February Investor Conferences Jan 29, 2024 Soleno Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Jan 24, 2024 Soleno Therapeutics Strengthens Leadership Team with Key Appointments Jan 05, 2024 Soleno Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Nov 10, 2023 Soleno Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Nov 07, 2023 Soleno Therapeutics Provides Corporate Update and Reports Third Quarter 2023 Financial Results Nov 06, 2023 Soleno Therapeutics Announces Peer-Reviewed Publication of Results from Long-Term Open-Label Study of DCCR in Prader-Willi Syndrome Oct 04, 2023 Correcting & Replacing -- Soleno Therapeutics Announces DCCR Data Presentation at the Foundation for Prader-Willi Research Symposium
Mar 06, 2024 Soleno Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full-Year 2023 Financial Results
Nov 07, 2023 Soleno Therapeutics Provides Corporate Update and Reports Third Quarter 2023 Financial Results
Nov 06, 2023 Soleno Therapeutics Announces Peer-Reviewed Publication of Results from Long-Term Open-Label Study of DCCR in Prader-Willi Syndrome
Oct 04, 2023 Correcting & Replacing -- Soleno Therapeutics Announces DCCR Data Presentation at the Foundation for Prader-Willi Research Symposium